Introduction: Covid19 predisposes to mucormycosis, probably due to diabetes, steroid and immunosuppressive status and is associated with high
morbidity and mortality. Present study aims to evaluate socio-demographic and clinical prole, its outcome, anatomical site of involvement and
covid vaccination status of patients of post-covid mucormycosis. Methods: It's a cross-sectional study conducted in GG Hospital, Jamnagar
between May to June 2020 with a total sample size of 264 patients. Results: The mean age of mucormycosis patients was 53.63 years. More than
three forth of patients had history of diabetes. About 85% patients were unvaccinated for covid19. The case fatality rate of mucormycosis was
23.10%. The most common types of mucormycosis was Rhinomucormycosis (51.5%). Conclusion: A fatal combination of diabetes and
indiscriminate use of steroids in covid19 increases possibility of mucormycosis. Discharge rate was 69%, with 23% mortality rate. This could be
due to delayed diagnosis of disease and consequent late initiation of treatment. A larger proportion of patients (86%) were unvaccinated for
covid19, that could led to increased probability to severe forms of covid 19 and subsequent oxygen therapy. Rhinomucormycosis is most common
form of presentation. Recommendation. Timely diagnosis and early initiation of treatment, strict glycemic control, and rational use of steroids
could save mucormycosis patients. Lack of awareness and ignorance could lead to severe covid19, that can lead to hypoxemia, and is sought to be
one of the reasons for mucormycosis
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.